295 related articles for article (PubMed ID: 6324325)
1. [Chronic senile cerebrovascular insufficiency. Effects of suloctidil and pentoxifylline on erythrocyte deformability].
Pilla G; Ciaponi A; Migliavacca A; Bonora C
Ric Clin Lab; 1983; 13 Suppl 3():459-64. PubMed ID: 6324325
[TBL] [Abstract][Full Text] [Related]
2. [Hemorrheological survey in a group with arteriosclerotic vascular disease treated with suloctidil].
Caimi G; Catania A; Frazzetta F; Capobianco D; Francavilla G; Romano A; Sarno A
Ric Clin Lab; 1983; 13 Suppl 3():465-8. PubMed ID: 6324326
[TBL] [Abstract][Full Text] [Related]
3. Suloctidil: long-term trial in the aged. Study of microcirculation, viscosity, red cell deformability, fibrinolysis and lipid fractions.
Merchan R; Zurita IE; Martinez JF
Arzneimittelforschung; 1985; 35(5):855-7. PubMed ID: 2992530
[TBL] [Abstract][Full Text] [Related]
4. Effects of long-term treatment with suloctidil on blood viscosity, erythrocyte deformability and total fibrinogen plasma levels in diabetic patients.
Roncucci R; De Hertogh R; Dormandy JA; Doumont J; Gurewich V; Lambelin G; Lansen J; Rottiers R; Souridis E; Van Stalle F; Versee L
Arzneimittelforschung; 1979; 29(4):682-4. PubMed ID: 582768
[TBL] [Abstract][Full Text] [Related]
5. Cerebrovascular circulatory disorders: new aspects of pathophysiology and therapy.
Müller R; Schröer R
J Med; 1979; 10(5):347-64. PubMed ID: 393790
[TBL] [Abstract][Full Text] [Related]
6. Pentoxifylline -- a biomedical profile.
Müller R
J Med; 1979; 10(5):307-29. PubMed ID: 393789
[TBL] [Abstract][Full Text] [Related]
7. Studies on vasoocclusive crisis of sickle cell disease. I. Effect of pentoxifylline.
Ambrus JL; Ambrus CM; Gastpar H; Bannerman R; Bettigole R; Friedman S
J Med; 1979; 10(6):445-56. PubMed ID: 299453
[TBL] [Abstract][Full Text] [Related]
8. The effect of pentoxifylline on the deformability of erythrocytes and on the muscular oxygen pressure in patients with chronic arterial disease.
Ehrly AM
J Med; 1979; 10(5):331-8. PubMed ID: 294470
[No Abstract] [Full Text] [Related]
9. [Erythrocyte filterability and treatment with pentoxifylline].
Valentini M; Sciannameo F; Francucci M; Tockner M; Sassano L; Allegra A
Ric Clin Lab; 1983; 13 Suppl 3():455-8. PubMed ID: 6673029
[TBL] [Abstract][Full Text] [Related]
10. Double-blind, crossover study of the clinical efficacy and the hemorheological effects of pentoxifylline in patients with occlusive arterial disease of the lower limbs.
Strano A; Davi G; Avellone G; Novo S; Pinto A
Angiology; 1984 Jul; 35(7):459-66. PubMed ID: 6380350
[TBL] [Abstract][Full Text] [Related]
11. [Clinical evaluation of the effects of pentoxifylline in patients with chronic peripheral circulatory disorders].
Strano A; Davì G; Novo S; Avellone G; Pinto A
Ric Clin Lab; 1981; 11 Suppl 1():303-11. PubMed ID: 7188117
[No Abstract] [Full Text] [Related]
12. Hemorheological effects of pentoxifylline on disturbed flow behavior of blood in patients with cerebrovascular insufficiency.
Ott E; Lechner H; Fazekas F
Eur Neurol; 1983; 22 Suppl 1():105-7. PubMed ID: 6884401
[TBL] [Abstract][Full Text] [Related]
13. [Role of the blood platelets in the atherosclerotic process and clinical use of a new drug, Suloctidil, with anti-aggregating activity].
Armani U; Piana A
Arch Maragliano Patol Clin; 1979; 35(2):57-62. PubMed ID: 233645
[No Abstract] [Full Text] [Related]
14. A new method of measuring red cell deformability and the effects of pentoxifylline.
Isogai Y; Mochizuki K; Ashikaga M
Curr Med Res Opin; 1981; 7(6):352-8. PubMed ID: 7238085
[TBL] [Abstract][Full Text] [Related]
15. Cerebral blood flow in patients with cerebrovascular disorders: study with pentoxifylline.
Hartmann A
Ric Clin Lab; 1981; 11 Suppl 1():243-6. PubMed ID: 7188111
[TBL] [Abstract][Full Text] [Related]
16. Pentoxifylline and cerebrovascular diseases.
Marcel GA; George C
Eur Neurol; 1983; 22 Suppl 1():89-97. PubMed ID: 6350013
[TBL] [Abstract][Full Text] [Related]
17. Erythrocyte deformability in a red cell ageing model.
Leonhardt H; Grigoleit HG; Reinhardt I
Ric Clin Lab; 1978; 8(1-2):65-71. PubMed ID: 705180
[TBL] [Abstract][Full Text] [Related]
18. Macro- and microrheological parameters of blood in patients with cerebral and peripheral atherosclerosis: the molecular change mechanisms after pentoxifylline treatment.
Muravyov AV; Bulaeva SV; Tikhomirova IA; Zamishlayev AV; Uzikova EV; Miloradov MJ
Clin Hemorheol Microcirc; 2011; 49(1-4):431-9. PubMed ID: 22214714
[TBL] [Abstract][Full Text] [Related]
19. The effect of pentoxifylline on red cell deformability in cerebrovascular accidents.
Martin P; Vives P
Curr Med Res Opin; 1980; 6(8):518-22. PubMed ID: 6248293
[TBL] [Abstract][Full Text] [Related]
20. Studies on platelet aggregation with pentoxifylline: effect on neoplastic disorders and other new indications.
Ambrus JL; Ambrus CM; Gastpar H
J Med; 1979; 10(5):339-45. PubMed ID: 119023
[No Abstract] [Full Text] [Related]
[Next] [New Search]
